Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Speech Analysis in ALS Patients With and Without Cognitive Abnormalities: Evaluation of Sensitivity and Disease Progression

NCT03868345 is registered in ClinicalTrials.gov with Barrow Neurological Institute as lead sponsor.

NCT NCT03868345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03868345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Speech Analysis in ALS Patients With and Without Cognitive Abnormalities: Evaluation of Sensitivity and Disease Progression
Lead sponsor
Barrow Neurological Institute
Phase
Observational
Overall status
Completed
Start date
February 18, 2019
Completion date
April 30, 2021
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als, amyotrophic lateral sclerosis, lou gehrig disease